Literature DB >> 25137293

Activation-induced cell death drives profound lung CD4(+) T-cell depletion in HIV-associated chronic obstructive pulmonary disease.

Iulia Popescu1, M Bradley Drummond, Lucio Gama, Tiffany Coon, Christian A Merlo, Robert A Wise, Janice E Clements, Gregory D Kirk, John F McDyer.   

Abstract

RATIONALE: As overall survival improves, individuals with HIV infection become susceptible to other chronic diseases, including accelerated chronic obstructive pulmonary disease (COPD).
OBJECTIVES: To determine whether individuals with HIV-associated COPD exhibit dysregulated lung mucosal T-cell immunity compared with control subjects.
METHODS: Using flow cytometry, we evaluated peripheral blood and lung mucosal T-cell immunity in 14 HIV(+)COPD(+), 13 HIV(+)COPD(-), and 7 HIV(-)COPD(+) individuals.
MEASUREMENTS AND MAIN RESULTS: HIV(+)COPD(+) individuals demonstrated profound CD4(+) T-cell depletion with reduced CD4/CD8 T-cell ratios in bronchoalveolar lavage-derived lung mononuclear cells, not observed in peripheral blood mononuclear cells, and diminished CD4(+) T cell absolute numbers, compared with control subjects. Furthermore, HIV(+)COPD(+) individuals demonstrated decreased pulmonary HIV-specific and staphylococcal enterotoxin B-reactive CD4(+) memory responses, including loss of multifunctionality, compared with HIV(+)COPD(-) control subjects. In contrast, lung mucosal HIV-specific CD8(+) T-cell responses were preserved. Lung CD4(+) T cells from HIV(+)COPD(+) individuals expressed increased surface Fas death receptor (CD95) and programmed death-1, but similar bronchoalveolar lavage viral loads as control subjects. However, programmed death-1 expression inversely correlated with HIV-specific lung CD4(+)IFN-γ(+) T-cell responses, suggesting functional exhaustion. Moreover, lung CD4(+) T cells from HIV(+)COPD(+) patients demonstrated increased basal and HIV antigen-induced expression of the early apoptosis marker annexin V compared with control subjects, which was significantly attenuated with anti-Fas blockade. Lastly, lung mucosal, but not blood, CD4(+)/CD8(+) ratios from HIV(+) patients significantly correlated with the FEV1, but not in HIV(-)COPD(+) patients.
CONCLUSIONS: Together, our results provide evidence for profound lung mucosal CD4(+) T-cell depletion via a Fas-dependent activation-induced cell death mechanism, along with impaired HIV-specific CD4(+) immunity as immunologic features of HIV-associated COPD.

Entities:  

Keywords:  COPD; HIV; T cells; apoptosis; immune activation

Mesh:

Substances:

Year:  2014        PMID: 25137293      PMCID: PMC4299615          DOI: 10.1164/rccm.201407-1226OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  45 in total

1.  Correlation of HIV-1 detection and histology in AIDS-associated emphysema.

Authors:  Martha M Yearsley; Philip T Diaz; Daren Knoell; Gerard J Nuovo
Journal:  Diagn Mol Pathol       Date:  2005-03

2.  CD8+ T-lymphocytes in peripheral airways of smokers with chronic obstructive pulmonary disease.

Authors:  M Saetta; A Di Stefano; G Turato; F M Facchini; L Corbino; C E Mapp; P Maestrelli; A Ciaccia; L M Fabbri
Journal:  Am J Respir Crit Care Med       Date:  1998-03       Impact factor: 21.405

Review 3.  Pathogenesis of COPD.

Authors:  John R Spurzem; Stephen I Rennard
Journal:  Semin Respir Crit Care Med       Date:  2005-04       Impact factor: 3.119

4.  Lack of chronic immune activation in HIV-infected chimpanzees correlates with the resistance of T cells to Fas/Apo-1 (CD95)-induced apoptosis and preservation of a T helper 1 phenotype.

Authors:  M L Gougeon; H Lecoeur; F Boudet; E Ledru; S Marzabal; S Boullier; R Roué; S Nagata; J Heeney
Journal:  J Immunol       Date:  1997-03-15       Impact factor: 5.422

5.  PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression.

Authors:  Cheryl L Day; Daniel E Kaufmann; Photini Kiepiela; Julia A Brown; Eshia S Moodley; Sharon Reddy; Elizabeth W Mackey; Joseph D Miller; Alasdair J Leslie; Chantal DePierres; Zenele Mncube; Jaikumar Duraiswamy; Baogong Zhu; Quentin Eichbaum; Marcus Altfeld; E John Wherry; Hoosen M Coovadia; Philip J R Goulder; Paul Klenerman; Rafi Ahmed; Gordon J Freeman; Bruce D Walker
Journal:  Nature       Date:  2006-08-20       Impact factor: 49.962

6.  Inflammation in bronchial biopsies of subjects with chronic bronchitis: inverse relationship of CD8+ T lymphocytes with FEV1.

Authors:  T C O'Shaughnessy; T W Ansari; N C Barnes; P K Jeffery
Journal:  Am J Respir Crit Care Med       Date:  1997-03       Impact factor: 21.405

7.  Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage.

Authors:  J V Giorgi; L E Hultin; J A McKeating; T D Johnson; B Owens; L P Jacobson; R Shih; J Lewis; D J Wiley; J P Phair; S M Wolinsky; R Detels
Journal:  J Infect Dis       Date:  1999-04       Impact factor: 5.226

8.  HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells.

Authors:  Michael R Betts; Martha C Nason; Sadie M West; Stephen C De Rosa; Stephen A Migueles; Jonathan Abraham; Michael M Lederman; Jose M Benito; Paul A Goepfert; Mark Connors; Mario Roederer; Richard A Koup
Journal:  Blood       Date:  2006-02-07       Impact factor: 22.113

9.  Analysis of apoptosis in lymph nodes of HIV-infected persons. Intensity of apoptosis correlates with the general state of activation of the lymphoid tissue and not with stage of disease or viral burden.

Authors:  C A Muro-Cacho; G Pantaleo; A S Fauci
Journal:  J Immunol       Date:  1995-05-15       Impact factor: 5.422

10.  Programmed cell death in peripheral lymphocytes from HIV-infected persons: increased susceptibility to apoptosis of CD4 and CD8 T cells correlates with lymphocyte activation and with disease progression.

Authors:  M L Gougeon; H Lecoeur; A Dulioust; M G Enouf; M Crouvoiser; C Goujard; T Debord; L Montagnier
Journal:  J Immunol       Date:  1996-05-01       Impact factor: 5.422

View more
  21 in total

1.  Incidence of chronic obstructive pulmonary disease in people with HIV in Ontario, 1996-2015: a retrospective population-based cohort study.

Authors:  Tony Antoniou; Zhan Yao; Janet Raboud; Andrea S Gershon
Journal:  CMAJ Open       Date:  2020-02-18

Review 2.  Mechanisms Underlying HIV-Associated Noninfectious Lung Disease.

Authors:  Rachel M Presti; Sonia C Flores; Brent E Palmer; Jeffrey J Atkinson; Catherine R Lesko; Bryan Lau; Andrew P Fontenot; Jesse Roman; John F McDyer; Homer L Twigg
Journal:  Chest       Date:  2017-04-17       Impact factor: 9.410

3.  Diverse fates of uracilated HIV-1 DNA during infection of myeloid lineage cells.

Authors:  Erik C Hansen; Monica Ransom; Jay R Hesselberth; Nina N Hosmane; Adam A Capoferri; Katherine M Bruner; Ross A Pollack; Hao Zhang; Michael Bradley Drummond; Janet M Siliciano; Robert Siliciano; James T Stivers
Journal:  Elife       Date:  2016-09-20       Impact factor: 8.140

4.  HIV Infection Is Associated With Increased Risk for Acute Exacerbation of COPD.

Authors:  Allison A Lambert; Gregory D Kirk; Jacquie Astemborski; Shruti H Mehta; Robert A Wise; M Bradley Drummond
Journal:  J Acquir Immune Defic Syndr       Date:  2015-05-01       Impact factor: 3.731

5.  HIV infection model of chronic obstructive pulmonary disease in mice.

Authors:  Patrick Geraghty; Eran Hadas; Boe-Hyun Kim; Abdoulaye J Dabo; David J Volsky; Robert Foronjy
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-01-19       Impact factor: 5.464

Review 6.  Obstructive Lung Diseases in HIV: A Clinical Review and Identification of Key Future Research Needs.

Authors:  M Bradley Drummond; Ken M Kunisaki; Laurence Huang
Journal:  Semin Respir Crit Care Med       Date:  2016-03-14       Impact factor: 3.119

Review 7.  Non-infectious Pulmonary Diseases and HIV.

Authors:  M Triplette; K Crothers; E F Attia
Journal:  Curr HIV/AIDS Rep       Date:  2016-06       Impact factor: 5.071

8.  Diversity of Human and Macaque Airway Immune Cells at Baseline and during Tuberculosis Infection.

Authors:  Richard F Silver; Amy J Myers; Jessica Jarvela; JoAnne Flynn; Tara Rutledge; Tracey Bonfield; Philana Ling Lin
Journal:  Am J Respir Cell Mol Biol       Date:  2016-12       Impact factor: 6.914

9.  HIV Suppression Restores the Lung Mucosal CD4+ T-Cell Viral Immune Response and Resolves CD8+ T-Cell Alveolitis in Patients at Risk for HIV-Associated Chronic Obstructive Pulmonary Disease.

Authors:  Iulia Popescu; M Bradley Drummond; Lucio Gama; Allison Lambert; Aki Hoji; Tiffany Coon; Christian A Merlo; Robert A Wise; Jeanne Keruly; Janice E Clements; Gregory D Kirk; John F McDyer
Journal:  J Infect Dis       Date:  2016-09-09       Impact factor: 5.226

Review 10.  Pulmonary disease in HIV-infected adults in the era of antiretroviral therapy.

Authors:  Meghan E Fitzpatrick; Ken M Kunisaki; Alison Morris
Journal:  AIDS       Date:  2018-01-28       Impact factor: 4.177

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.